Pfizer CEO Albert Bourla defends the COVID vaccine's science, transparency, and the company's reputation in a candid conversation about trust and division.

Albert Bourla — CEO of Pfizer, the pharmaceutical company that developed one of the first COVID-19 vaccines with BioNTech. A veterinarian by training, he had been with Pfizer for 28 years and became CEO in 2019.
Lex Fridman interviews Pfizer CEO Albert Bourla about the development of the COVID-19 vaccine, the science behind clinical trials, and the deep public distrust of big pharma and institutions. Fridman repeatedly presses Bourla with hard questions about FDA transparency, conflicts of interest, marketing, vaccine mandates, and Pfizer's past legal settlements. Bourla defends the rigor of the regulatory process and argues that focusing on doing the right thing, not money, is what drives value. They also discuss the new antiviral pill Paxlovid, vaccinating children, ivermectin, and the broader theme of healing societal division through honest, empathetic communication.
Books, products and media the guest or host genuinely endorsed here — with the buy link.
Affiliate link — we may earn a commission at no extra cost to you.
Pfizer
“this is a real game changer this is a course of treatment that you get only if you get the disease you get covered” — Albert Bourla 00:59:39Find it on Amazon
Pfizer / BioNTech
“the fisa vaccine by the way of which i took two shots no booster yet is unsafe what do you say to people that say that” — Albert Bourla 00:39:30Find it on Amazon